Ephrin Receptor
Ephrin receptor inhibitors target Eph receptors, a family of receptor tyrosine kinases that interact with membrane-bound ephrin ligands. Ephrin signaling is crucial for cell positioning, tissue patterning, and angiogenesis. Dysregulation of this pathway is implicated in cancer, neurodegenerative diseases, and developmental disorders. At CymitQuimica, we provide Ephrin receptor inhibitors to support your research in developmental biology, oncology, and neurobiology.
Found 23 products of "Ephrin Receptor"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
AWL-II-38.3
CAS:<p>AWL-II-38.3 is a highly potent EphA3 inhibitor with potent kinase inhibitory activity against EphA3.Cost-effective and quality-assured.</p>Formula:C23H18F3N5O3Purity:99.03% - 99.57%Color and Shape:SolidMolecular weight:469.42EphA2 agonist 1
CAS:<p>Compound 7bg is a potent, selective EphA2 agonist targeting overexpressed glioblastoma cells.</p>Formula:C50H58N12O12Color and Shape:SolidMolecular weight:1019.07ALW-II-49-7
CAS:<p>ALW-II-49-7 is a selective and potent inhibitor of EphB2 kinase with an EC50 value of 40 nM in cell.</p>Formula:C21H17F3N4O2Purity:99.72%Color and Shape:SoildMolecular weight:414.38Nuzefatide
CAS:<p>Nuzefatide is a peptide that binds to liver protein receptors.</p>Formula:C105H162N32O27S3Color and Shape:SolidMolecular weight:2400.80SA-PA
<p>SA-PA, a self-assembled intracellular PROTAC leveraging azide-alkyne click chemistry, selectively degrades VEGFR-2, PDGFR-β, and EphB4 proteins within U87 cells</p>Formula:C40H32ClF3N10O8Purity:98%Color and Shape:SolidMolecular weight:873.19PKMYT1-IN-8
<p>PKMYT1-IN-8 (Compound 137) is an inhibitor of PKMYT1, with an IC50 value of 9 nM. It also inhibits EPHB3, EPHA1, KIT, EPHB1, EPHA2, EPHA3, and EPHB2, exhibiting IC50 values of 1.79, 3.17, 4.29, 6.32, 6.83, 8.10, and 10.9 μM, respectively. Additionally, PKMYT1-IN-8 suppresses the proliferation of cancer cells OVCAR3 with a GI50 of 2.02 μM.</p>Formula:C17H16F3N5O2Color and Shape:SolidMolecular weight:379.336AZ12672857
CAS:<p>AZ12672857 is an inhibitor of EphB4 with IC50 of 1.3 nM.</p>Formula:C26H30N8O2Purity:98.99%Color and Shape:SolidMolecular weight:486.57UniPR1449
<p>UniPR1449 is an EphA2 receptor antagonist with a KD of 3.8±2.4 μM, which is significant in cancer pathophysiology [1].</p>Purity:98%Color and Shape:Odour SolidKYL peptide
CAS:<p>EphA4 inhibitor, Kd 0.8 μM, blocks EphA4-EphrinA5; avoids AβO damage, preserves spines & LTP; long half-life (8-12h), neuroprotective.</p>Formula:C74H108N14O17Purity:98%Color and Shape:SolidMolecular weight:1465.75Ehp-inhibitor-2
CAS:<p>Ehp-inhibitor-2 is an Eph family tyrosine kinase inhibitor targeting Eph receptors.</p>Formula:C17H13N5OPurity:97.88%Color and Shape:SolidMolecular weight:303.32NVP-BHG712 isomer
CAS:<p>NVP-BHG712 isomer shows conserved non-bonded binding to EPHA2 and EPHB4.</p>Formula:C26H20F3N7OPurity:99.14%Color and Shape:SolidMolecular weight:503.48JI-101
CAS:<p>JI-101 (CGI-1842) is an oral multi-kinase inhibitor that targets VEGFR-2, PDGFR-β, and EphB4.</p>Formula:C22H20BrN5O2Purity:99.41% - 99.97%Color and Shape:SolidMolecular weight:466.33NVP-BHG712
CAS:<p>NVP-BHG712 is a specific EphB4 inhibitor with ED50 of 25 nM that discriminates between VEGFR and EphB4 inhibition; also shows activity against c-Raf, c-Src and</p>Formula:C26H20F3N7OPurity:97.32% - 98.63%Color and Shape:SolidMolecular weight:503.48Eph inhibitor 2
CAS:<p>Eph inhibitor 2 is an Eph family tyrosine kinase inhibitor targeting Eph receptors.</p>Formula:C18H15N5OPurity:99.01%Color and Shape:SolidMolecular weight:317.34Tesevatinib
CAS:<p>Tesevatinib (XL-647) is an oral, multi-targeted tyrosine kinase inhibitor.Cost-effective and quality-assured.</p>Formula:C24H25Cl2FN4O2Purity:97.89% - 98.66%Color and Shape:SolidMolecular weight:491.39ALW-II-41-27
CAS:<p>ALW-II-41-27 (Eph receptor tyrosine kinase inhibitor), an Eph receptor tyrosine kinase inhibitor, is used for cancer therapy.</p>Formula:C32H32F3N5O2SPurity:97.01% - 99.52%Color and Shape:SolidMolecular weight:607.69123C4
CAS:<p>123C4 is a potent, selective and competitive agonist of the receptor tyrosine kinase EPHA4 (Ki=0.65 μM)[1].</p>Formula:C43H47ClN8O6Purity:98.94%Color and Shape:SolidMolecular weight:807.34EphA2 agonist 2
CAS:<p>EphA2 agonist 2 (Lead compound) is a selective agonist targeting the EphA2 receptor, exhibiting antitumor properties and the ability to cross the blood-brain</p>Formula:C40H56N10O6Color and Shape:SolidMolecular weight:772.94UniPR129
CAS:<p>UniPR129 is a competitive Eph-ephrin antagonist agent that acts by blocking in vitro angiogenesis at low micromolar concentrations.</p>Formula:C36H52N2O4Purity:98%Color and Shape:SolidMolecular weight:576.81LDN-211904 oxalate
CAS:<p>LDN-211904 oxalate (LDN211904 oxalate) is a selective and efficient EphB3 inhibitor with antitumor activity, useful in neurodegenerative disease research.</p>Formula:C21H21ClN4O5Purity:99.87%Color and Shape:SolidMolecular weight:444.87UniPR505
CAS:<p>UniPR505 is a potent EphA2 antagonist (IC50: 0.95 µM), a novel 3α-carbamoyloxy derivative with antiangiogenic properties.</p>Formula:C39H57N3O5Purity:98.23%Color and Shape:SolidMolecular weight:647.89UniPR1447
CAS:<p>UniPR1447 is a dual antagonist for both EphA2 and EphB2 receptors, exhibiting an IC50 value of 6.6 μM against EphA2-ephrin-A1 binding [1].</p>Formula:C36H50N2O4Purity:98%Color and Shape:SolidMolecular weight:574.79UniPR500
CAS:<p>UniPR500, a derivative of UniPR129, is a competitive antagonist for the EphA2 receptor, with a Ki of 0.78 μM. It reduces the binding of biotinylated Ephrin-A1 to EphA2 in a dose-dependent manner, exhibiting an IC50 value of 1.1 μM.</p>Formula:C36H51N3O4Color and Shape:SolidMolecular weight:589.808
